1018P Characterization of liver function tests following tebentafusp in phase III randomized trial comparing tebentafusp with investigator’s choice in first line metastatic uveal melanoma (mUM)
Year: 2021
Type: article
Source: Annals of Oncology
Authors: B. Chmielowski, E. Kapiteijn, P.A. Ascierto, F. Meier, S.E. Abdullah, S. Lockwood, P. Mendez, I. Puzanov
Institutions: University of California, Los Angeles, Leiden University Medical Center, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", University Hospital Carl Gustav Carus, Nationales Centrum für Tumorerkrankungen Dresden, Technische Universität Dresden, Immunocore (United States), Roswell Park Comprehensive Cancer Center
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3203261241